AKASA
PrivateLast Round
Early Funding
Jun 18, 2024
Est. Valuation
$94.43M
Total Funding Raised
$325M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AKASA operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was an Early Funding round in June 2024.
AKASA is a healthcare technology company that provides generative AI solutions to streamline revenue cycle management for health systems.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AKASA Comparables
Compare AKASA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adonis | 87% | |
| Janus Health | 86% | |
| Arintra | 85% |
For institutional investors. Book with your work email.
AKASA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 18, 2024 | ||||
| Series B | Mar 23, 2021 | ||||
| Series A | Jun 10, 2020 | ||||
| Seed | Dec 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AKASA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Early Funding, Series C, Series B, Seed, Series A |
| Bond Capital | Series B |
| Costanoa Ventures | Early Funding, Seed, Series C, Series B, Series A |
| Coatue Management | Series C |
| BOND | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 22, 2026
CEO ranked among Top 50 Healthcare Technology CEOs.
- Mar 22, 2026
Certified for 6 consecutive years.
For institutional investors. Book with your work email.
AKASA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AKASA's valuation, stock price, and market status.
Is AKASA a public or private company?
AKASA is a private company.
What is the current stock price of AKASA?
AKASA is a private company, so its shares have no public market price. Caplight tracks AKASA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AKASA worth (valuation)?
AKASA's valuation is estimated at $94.4M based on funding round data.
Can I buy AKASA stock?
AKASA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AKASA's last funding round?
AKASA's most recent funding round was Early Funding on June 18, 2024.
Who are the main investors in AKASA?
Key investors in AKASA include Andreessen Horowitz, Bond Capital, Coatue Management, BOND.
Will AKASA IPO soon?
No public IPO plans have been announced for AKASA.
How can I track AKASA secondary market activity?
Caplight tracks bids, offers, and trades in AKASA's shares on secondary markets.